The third episode of Oncopeptalks – Industry Congresses

Join David Augustsson, Director of Corporate Affairs at Oncopeptides, for the third episode of Oncopeptalks – a short company update aimed at investors where various members of the Oncopeptides team will be able to answer questions and address issues from the investor community.

In this edition, we focus on medical congresses and their importance for the marketing and sales of drugs. Sofia Heigis, CEO of Oncopeptides, joins to give her take on some of the key events in the world of multiple myeloma.

Watch the video below (Also available in Swedish, with similar content).

We do apologize for the sporadic sound issues!

If you have any questions or issues that you´d like to have addressed in future editions, reach out to David at